Released Nov 8, 2016, after the close
10-Q filed Nov 9, 2016, 40 days after period end · 0001162194-16-000248
Q3 2016 · 10-Q
Revenue$22.19M$22.19M −22.5% vs Q3 2015−21.2% vs Q2 2016
Net Income-$19.79M-$19.79M N/M vs Q3 2015N/M vs Q2 2016
EPS Diluted-$0.68-$0.68 N/M vs Q3 2015N/M vs Q2 2016
Operating Income-$18,483,000N/M
Operating Cash Flowderived-$13,262,000N/M
Free Cash Flowderived-$14,971,000N/M
Margins · derived
Operating margin-83.3%−56.0 pt vs Q3 2015
Net margin-89.2%−56.8 pt vs Q3 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $22.19M | $28.64M | $29.64M | $18.29M |
| Net Income | -$19.79M | -$9.27M | -$13.79M | -$4.29M |
| EPS Diluted | -$0.68 | -$0.32 | -$0.49 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR